1. Comparison of insulin degludec (IDeg)/insulin Aspart (IAsp) co‐formulation therapy twice‐daily with free combination of GLP‐1 receptor agonist liraglutide plus insulin degludec in Tochigi: IDEAL Trial. Issue 4 (9th November 2020) Authors: Aso, Yoshimasa; Takada, Yoshihisa; Tomotsune, Ken; Chiba, Yasuko; Matsumura, Mihoko; Jojima, Teruo; Sato, Minoru; Fujita, Nobuya; Kuroda, Hisamoto; Murano, Shunichi; Usui, Isao Journal: International journal of clinical practice Issue: Volume 75:Issue 4(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of insulin degludec versus insulin glargine on glycemic control and daily fasting blood glucose variability in insulin-naïve Japanese patients with type 2 diabetes: I'D GOT trial. (August 2017) Authors: Aso, Yoshimasa; Suzuki, Kunihiro; Chiba, Yasuko; Sato, Minoru; Fujita, Nobuya; Takada, Yoshihisa; Murano, Shunichi; Kuroda, Hisamoto Journal: Diabetes research and clinical practice Issue: Volume 130(2017) Page Start: 237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗